Skip to main content
SpringerLink
Log in

Genetic modulation of plasma fibrinogen concentrations: Possible importance of interleukin-6

  • Basic Research
  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

Current knowledge indicates that high plasma levels of fibrinogen, a key protein in the hemostatic system, help predict the major ischemic complications of atherosclerosis, that is, stroke and myocardial infarction. Molecular variations at the fibrinogen genes loci have been shown to regulate fibrinogen concentrations in plasma. However, it is also known that fibrinogen is an acute phase reactant and that its plasma levels are increased by the inflammatory mediator interleukin-6 (IL-6) as a consequence of stimulated gene expression. Certain risk factors for atherosclerosis are known to cause inflammatory and proliferative events within the vessel wall, especially when combined. This raises the question of whether and to what extent high plasma fibrinogen levels in patients with major thrombotic complications of atherosclerosis could be the epiphenomena of as yet poorly elucidated issues in vascular medicine (i.e., severity of vascular damage). Screening of the fibrinogen genes loci in both young patients with established risk factors and in patients evaluated for regression of atherosclerosis who have participated in risk factor reduction programs may provide further insight into the role of genetic factors in the development of atherosclerosis and in the regulation of plasma fibrinogen levels.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cook NS, Ubben D. Fibrinogen as a major risk factor in cardiovascular disease. TIPS 1990;11:444–451.

    Google Scholar 

  2. Di Minno G, Mancini M. Measuring plasma fibrinogen to predict stroke and myocardial infarction. Arteriosclerosis 1990;10:1–7.

    Google Scholar 

  3. Meade TW, Chakrabarti R, Haines AP, et al. Hemostatic function and cardiovascular death: Early result of a prospective study. Lancet 1980;1:1050–1054.

    Google Scholar 

  4. Meade TW, Mellows S, Brozovic M, et al. Hemostatic function and ischemic heart disease: Principal results of the Norwich Park Study. Lancet 1986;2:533–537.

    Google Scholar 

  5. Wilhelmsen K, Svardsudd K, Korsan-Bengsten K, et al. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984;311:501–505.

    Google Scholar 

  6. Balleisen L, Bailey J, Epping PH, et al. Epidemiology study on factor VII, factor VIII and fibrinogen in an industrial population. 1. Baseline data on the relation to age, gender, body weight, smoking, alcohol, pill using and menopause. Thromb Haemost 1985;54:475–479.

    Google Scholar 

  7. Stone MC, Thorp JM. Plasma fibrinogen: A major coronary risk factor. J R Coll Pract 1985;35:565–569.

    Google Scholar 

  8. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB. Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA 1987;258:1183–1186.

    Google Scholar 

  9. Heirich J, Schulte H, Balleisen L, et al. Predictive value of haemostatic variables in the PROCAM study. Thromb Haemost 1991;65:815–818.

    Google Scholar 

  10. Kannel WB, D'Agostino RB, Belanger AJ. Fibrinogen, cigarette smoking and risk of cardiovascular disease: Insights from the Framingham Study. Am Heart J 1987;113:1006–1010.

    Google Scholar 

  11. Meade TW, Imeson J, Stirling Y. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischemic heart disease. Lancet 1987;2:986–988.

    Google Scholar 

  12. Krobot K, Hense HW, Cremer P, et al. Determinants of plasma fibrinogen: Relation to body weight, waist to hip ratio, smoking, alcohol, age and sex. Arterioscler Thromb 1992;12:780–788.

    Google Scholar 

  13. Fuller JH, Keen H, Jarrett RJ, et al. Haemostatic variables associated with diabetes and its complications. Br Med J 1979;2:964–966.

    Google Scholar 

  14. Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor: A meta-analysis and review of the literature. Ann Intern Med1993;118:956–963.

    Google Scholar 

  15. Meade TW, Chakrabarti R, Haines AP, et al. Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. Br Med J 1979;1:153–156.

    Google Scholar 

  16. Hamsten A, Iselius L, de Faire U, Blomback M. Genetic and cultural inheritance of plasma fibrinogen concentrations. Lancet 1987;2:988–90.

    Google Scholar 

  17. Berg K, Kierulf P. DNA polymorphisms at fibrinogen loci and plasma fibrinogen concentrations. Clin Genet 1989;36:229–235.

    Google Scholar 

  18. Thompson SG, Martin JC, Meade TW. Sources of variability in coagulation factor assays. Thromb Haemost 1987;58:1073–1077.

    Google Scholar 

  19. Henschen A, McDonagh J. Fibrinogen, fibrin and factor XIII. In: Zwaal RFA, Hemker HC, eds. Blood Coagulation. Amsterdam: Elsevier, 1986:171–241.

    Google Scholar 

  20. Hoeprich PD, Doolittle RF. Dimeric half-molecules of human fibrinogen are joined through disulphide bonds in an antiparallel orientation. Biochemistry 1983;22:2049–55.

    Google Scholar 

  21. Doolittle RF, Watt KWK, Cottrell BA, et al. The amino acid sequence of the α-chain of human fibrinogen. Nature 1979;280:464–468.

    Google Scholar 

  22. Chung DW, Harris JE, Davie EW. Nucleotide sequences of the three genes coding for human fibrinogen. In: Liu CY, Chien S, eds. Fibrinogen, Thrombosis, Coagulation and Fibrinolysis. New York: Plenum, 1990:39–48.

    Google Scholar 

  23. Marino MW, Fuller GM, Elder FFB. Chromosomal localisation of human and rat alpha, beta and gamma fibrinogen genes by in situ hybridation. Cytogenet Cell Genet 1986:42:36–41.

    Google Scholar 

  24. Buetow KH, Shiang R, Nakamura Y, et al. A multipoint genetic map and new RFLPs for human chromosome 4. Cytogenet Cell Genet 1989;51:973.

    Google Scholar 

  25. Kant JA, Fornace AJ, Saxe D, et al. Evolution and organization of the fibrinogen locus on chromosome 4: Gene duplication accompanied by transposition and inversion. Proc Natl Acad Sci USA 1985;82:2344–2348.

    Google Scholar 

  26. Kant JA, Lord ST, Crabtree GR. Partial mRNA sequence for human Aα, Bβ, and γ fibrinogen chains: Evolutionary and functional implications. Proc Natl Acad Sci USA 1983;80:3953–3957.

    Google Scholar 

  27. Yu S, Sher B, Kudrik B, Redman C. Intracellular assembly of human fibrinogen. J Biol Chem 1984;259:10574–10581.

    Google Scholar 

  28. Ptashne M. How eukaryotic transcriptional activators work. Nature 1988;335:683–689.

    Google Scholar 

  29. Huber P, Laurent M, Dalmon J. Human β-fibrinogen gene expression. Upstream sequences involved in its tissue specific expression and its dexamethasone and interleukin 6 stimulation. J Biol Chem 1990;265:5695–5701.

    Google Scholar 

  30. Roy S, Mukhopadhyay G, Redman C. Regulation of fibrinogen assembly. J Biol Chem 1990;265:6389–6393.

    Google Scholar 

  31. Roy S, Overton O, Redman C. Overexpression of any fibrinogen chain by Hep G2 cells specifically elevates the expression of the other two chains. J Biol Chem 1994;269:691–695.

    Google Scholar 

  32. Fey GH, Fuller GM. Regulation of the acute phase gene expression by inflammatory mediators. Mol Biol Med 1987;4:323–328.

    Google Scholar 

  33. Hassan J, Chelucci C, Peschle C, Sorrentino V. Transforming growth factor β (TGF-β) inhibits expression of fibrinogen and factor VII in a hepatoma cell line. Thromb Haemost 1992;67:478–483.

    Google Scholar 

  34. Heinrich PC, Castell JV, Andus T. Interleukin 6 and the acute phase response. Biochem J 1990;265:621–636.

    Google Scholar 

  35. Di Minno G, Mancini M. Drugs affecting plasma fibrinogen levels. Cardiovasc Drug Ther 1992;6:319–321.

    Google Scholar 

  36. Humphries SE, Imam AMA, Robbins TP, et al. The identification of a DNA polymlorphism of the α fibrinogen gene and the regional assignment of the human fibronogen genes to 4q26-qter. Hum Genet 1984;68:148–153.

    Google Scholar 

  37. Murray JC, Buetow K, Chung D, Aschbacher A. Linkage disequilibrium of RFLP's at the beta fibrinogen (FGB) and gamma fibrinogen (FGG) loci on chromosome 4. Cytogenet Cell Genet 1986;40:707–708.

    Google Scholar 

  38. Aschbacher A, Buetow K, Chung D, et al. Linkage disequilibrium of RFLP's associated with α, β, and γ fibrinogen predict gene order on chromosome 4. Am J Hum Genet 1985;37:186A.

    Google Scholar 

  39. Thomas AE, Green FR, Kelleher CH, et al. Variation in the promoter region of the β fibrinogen gene is associated with plasma fibrinogen levels in smokers and non-smokers. Thromb Haemost 1991;65:487–490.

    Google Scholar 

  40. Baumann RE, Henschen AH. Human fibrinogen polymorphic site analysis by restriction endonuclease digestion and allele-specific polymerase chain reaction amplification: Identification of polymorphisms at position Aα312 and Bβ448. Blood 1993;82:2117–2124.

    Google Scholar 

  41. Thomas AE, Green FR, Cruickshank K, Humphries SE. The HaeIII and HindIII polymorphisms of the β fibrinogen gene: Racial differences in frequency and association. Thromb Haemost 1991;65:897.

    Google Scholar 

  42. Humphries SE, Cook M, Dubovitz M, et al. Role of genetic variation at the fibrinogen locus in the determination of plasma fibrinogen concentrations. Lancet 1987;1:1452–1455.

    Google Scholar 

  43. Thomas AE, Lamium H, Humphries SE, Green F. Linkage disequilibrium across the fibrinogen locus as shown by five genetic polymorphisms, G/A-455(HaeIII), C/T-148(HindIII/AluI), T/G+1689 (AvaII), and BcII (β-Fibrinogen) and TaqI (α-Fibrinogen), and their detection by PCR. Hum Mut 1994;3:79–81.

    Google Scholar 

  44. Snowden C, Houlston R, Laker MF, et al. Plasma fibrinogen levels and fibrinogen genotype in non-insulin dependent diabetics. Dis Markers 1992;10:159–168.

    Google Scholar 

  45. Fowkes FGR, Connor JM, Smith FB, et al. Fibrinogen genotype and risk of peripheral atherosclerosis. Lancet 1992;339:693–696.

    Google Scholar 

  46. Baumann RE, Henschen AH. Genetic variation in human Bβ fibrinogen gene promoter influences formation of a specific DNA-protein complex with the interleukin 6 response element. Thromb Haemost. 1993;69:1515A.

  47. Baumann RE, Henschen AH. Linkage disequilibrium relationships among four polymorphisms within the human fibrinogen gene cluster. Hum Genet 1994;94:165–170.

    Google Scholar 

  48. Connor JM, Fowkes FGR, Wood J, et al. Genetic variation at fibrinogen loci and plasma fibrinogen levels. J Med Genet1992;29:480–482.

    Google Scholar 

  49. Scarabin PJ, Bara L, Ricard S, et al. Genetic variation at the β-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM study. Arteriosc Thromb 1993;13:886–891.

    Google Scholar 

  50. Green F, Hamsten A, Blomback M, Humprhies S. The role of β-fibrinogen genotype in determining plasma fibrinogen levels in young survivors of myocardial infarction and healthy controls from Sweden. Thromb Haemost 1993;70:915–920.

    Google Scholar 

  51. Koster T, Rosendaal FR, Reitsma PH, et al. Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms. The Leyden Thrombophilia Study (LETS). Thromb Haemost 1994;71:719–722.

    Google Scholar 

  52. Margaglione M, Grandone E, Vecchione G, et al. Family history and plasma fibrinogen concentrations in subjects attending a metabolic ward. Thromb Haemost 1995;73:579–583.

    Google Scholar 

  53. Stuart J, George AJ, Davies AJ, Aukland A, Hurlow RA. Haematological stress syndrome in atherosclerosis. J Clin Pathol 1981;34:464–467.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. IRCCS, “Casa Sollievo della Sofferenza,” S. Giovanni Rotondo (FG) and Clinica Medica, Institute of Internal Medicine and Metabolic Diseases, University of Naples, II, Federico, Italy

    Maurizio Margaglione, Elvira Grandone, Francesco Paolo Mancini & Giovanni Di Minno M.D.

Authors
  1. Maurizio Margaglione
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elvira Grandone
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Francesco Paolo Mancini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Giovanni Di Minno M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Margaglione, M., Grandone, E., Paolo Mancini, F. et al. Genetic modulation of plasma fibrinogen concentrations: Possible importance of interleukin-6. J Thromb Thrombol 3, 51–56 (1996). https://doi.org/10.1007/BF00226411

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00226411

Key words

Search

Navigation